Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,835 papers from all fields of science
Search
Sign In
Create Free Account
EB 1089
Known as:
EB-1089
, EB1089
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
seocalcitol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery
Gerald DeMasters
,
Xu Di
,
I. Newsham
,
R. Shiu
,
D. Gewirtz
Molecular Cancer Therapeutics
2006
Corpus ID: 33335645
1,25-Dihydroxyvitamin D3 and vitamin D3 analogues, such as EB 1089, potentiate the response to ionizing radiation in breast tumor…
Expand
Highly Cited
2003
Highly Cited
2003
Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
R. Lin
,
Tian-tian Wang
,
W. Miller
,
John H. White
Endocrinology
2003
Corpus ID: 1673547
Treatment of cancer cells with 1,25-dihydroxyvitamin D3 [1,25(OH)(2)D(3)] or its analogs induces growth arrest and expression of…
Expand
Highly Cited
2003
Highly Cited
2003
Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice
G. Zinser
,
Kevin G McEleney
,
J. Welsh
Molecular and Cellular Endocrinology
2003
Corpus ID: 25798740
2003
2003
Effects of Seocalcitol (EB1089) on Nitrosomethyl Urea-Induced Rat Mammary Tumors
K. Colston
,
G. Pirianov
,
E. Bramm
,
Karin Jexner Hamberg
,
L. Binderup
Breast Cancer Research and Treatment
2003
Corpus ID: 23898605
Although 1,25-dihydroxyvitamin D3 is a potent cell-differentiating agent, its use in cancer prevention or therapy is precluded…
Expand
Highly Cited
2002
Highly Cited
2002
Vitamin D receptor‐dependent antitumour effects of 1,25‐dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer
G. Oades
,
K. Dredge
,
R. Kirby
,
K. Colston
BJU International
2002
Corpus ID: 12922563
Objective To determine the in vitro and in vivo effects of 1,25‐dihydroxyvitamin D 3 (calcitriol) and two newer less…
Expand
2002
2002
Vitamin D and Its Analog EB1089 Induce p27 Accumulation and Diminish Association of p27 with Skp2 Independent of PTEN in Pituitary Corticotroph Cells
W. Liu
,
S. Asa
,
S. Ezzat
Brain Pathology
2002
Corpus ID: 26271584
Disruption of the gene for the cyclin dependent kinase inhibitor (CDKI) p27/kip1 results in pituitary corticotroph hyperplasia…
Expand
2001
2001
Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells
SS Larsen
,
I. Heiberg
,
AE Lykkesfeldt
British Journal of Cancer
2001
Corpus ID: 11008166
Most breast cancer patients treated with anti-oestrogens will eventually develop resistance towards treatment. Therefore it is…
Expand
1999
1999
Potentiation by vitamin D analogs of TNFα and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2
G. Pirianov
,
C. Danielsson
,
C. Carlberg
,
S. Y. James
,
K. Colston
Cell Death and Differentiation
1999
Corpus ID: 9867087
Synthetic analogs of vitamin D induce apoptosis in cultured breast cancer cells and cause regression of experimentally-induced…
Expand
Highly Cited
1997
Highly Cited
1997
Vitamin D3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model
J. Akhter
,
Xianghai Chen
,
P. Bowrey
,
E. Bolton
,
D. Morris
Diseases of the Colon & Rectum
1997
Corpus ID: 39351878
PURPOSE: In this study, we investigated the effect of the vitamin D3analog, EB1089, on the growth of subcutaneous xenografts of…
Expand
Highly Cited
1994
Highly Cited
1994
All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes.
G. Brown
,
C. Bunce
,
D. Rowlands
,
G. Williams
Leukemia
1994
Corpus ID: 29382091
A basis for differentiation therapy of leukemias is provided by knowledge of agents which induce specific lineage maturation. All…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE